136 related articles for article (PubMed ID: 3876220)
1. Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease.
Soulillou JP; Douillard JY; Vie H; Harousseau JL; Guenel J; le Mevel-le Pourhiet A; le Mevel B
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):935-9. PubMed ID: 3876220
[TBL] [Abstract][Full Text] [Related]
2. Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.
Damle RN; Advani SH; Gangal SG
Cancer Immunol Immunother; 1991; 34(3):205-10. PubMed ID: 1756538
[TBL] [Abstract][Full Text] [Related]
3. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
Zamkoff KW; Reeves WG; Paolozzi FP; Poiesz BJ; Comis RL; Tomar RH
Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
[TBL] [Abstract][Full Text] [Related]
4. Cytokinetic basis for the impaired activation of lymphocytes from patients with primary intracranial tumors.
Elliott LH; Brooks WH; Roszman TL
J Immunol; 1984 Mar; 132(3):1208-15. PubMed ID: 6319491
[TBL] [Abstract][Full Text] [Related]
5. Lymphocyte subsets, phytohaemagglutinin responsiveness of blood lymphocytes, and interleukin 2 production in sarcoidosis.
Chailleux E; Bignon JD; Peyrat MA; Godard A; Soulillou JP
Thorax; 1985 Oct; 40(10):768-73. PubMed ID: 3877349
[TBL] [Abstract][Full Text] [Related]
6. Impaired IL2 production by lymphocytes of patients with systemic lupus erythematosus.
de Faucal P; Godard A; Peyrat MA; Moreau JF; Soulillou JP
Ann Immunol (Paris); 1984; 135D(2):161-72. PubMed ID: 6335009
[TBL] [Abstract][Full Text] [Related]
7. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
8. [Abnormal regulation in the production of IL2 in Hodgkin's disease].
Marchiol C; Kaplan C; Chouaib S; Janvier M; Ferme C; Muller JY; Fradelizi D
C R Acad Sci III; 1985; 301(6):283-8. PubMed ID: 3928105
[TBL] [Abstract][Full Text] [Related]
9. Production of and response to interleukin-2 in peripheral blood lymphocytes of cancer patients.
Wanebo HJ; Pace R; Hargett S; Katz D; Sando J
Cancer; 1986 Feb; 57(3):656-62. PubMed ID: 3484660
[TBL] [Abstract][Full Text] [Related]
10. Impaired proliferative response and low interleukin-2 production in patients with lymphoma.
Musatti CC; Yasaka K; Santos LM
Braz J Med Biol Res; 1987; 20(3-4):351-62. PubMed ID: 3502537
[TBL] [Abstract][Full Text] [Related]
11. Multiple defects of T helper cell function in newly diagnosed patients with Hodgkin's disease.
Clerici M; Ferrario E; Trabattoni D; Viviani S; Bonfanti V; Venzon DJ; Clerici E; Shearer GM; Villa ML
Eur J Cancer; 1994; 30A(10):1464-70. PubMed ID: 7833103
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of interleukin-2 production in human lymphocytes by two new quinolone derivatives.
Zehavi-Willner T; Shalit I
Lymphokine Res; 1989; 8(1):35-46. PubMed ID: 2785621
[TBL] [Abstract][Full Text] [Related]
13. Production of interleukin-2 and expression of tac antigen in Hodgkin disease.
Joshi NN; Mukhopadhyay R; Advani SH; Gangal SG
Cancer Detect Prev Suppl; 1987; 1():137-43. PubMed ID: 2825998
[TBL] [Abstract][Full Text] [Related]
14. Association of an interleukin abnormality with the T cell defect in Hodgkin's disease.
Ford RJ; Tsao J; Kouttab NM; Sahasrabuddhe CG; Mehta SR
Blood; 1984 Aug; 64(2):386-92. PubMed ID: 6611180
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 production by peripheral blood lymphocytes in allograft recipients during acute rejection episodes.
Vie H; Bonneville M; Cariou R; Moreau JF; Soulillou JP
Kidney Int; 1985 Sep; 28(3):553-7. PubMed ID: 3906228
[TBL] [Abstract][Full Text] [Related]
16. In vitro correction of the interleukin-2 and interferon-gamma defect in multiple sclerosis.
Vervliet G; Schandené L
Clin Exp Immunol; 1985 Sep; 61(3):556-61. PubMed ID: 3935348
[TBL] [Abstract][Full Text] [Related]
17. Effect of exogenous interleukins on in vitro responses of T lymphocytes from patients with Hodgkin disease.
Mukhopadhyaya R; Advani SH; Gangal SG
Cancer Detect Prev; 1987; 10(5-6):445-51. PubMed ID: 3494512
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
Deshazo RD; Ewel C; Londono S; Metzger Z; Hoffeld JT; Oppenheim JJ
Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
[TBL] [Abstract][Full Text] [Related]
19. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
Passwell J; Levanon M; Davidsohn J; Ramot B
Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
[TBL] [Abstract][Full Text] [Related]
20. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis.
Merrill JE; Mohlstrom C; Uittenbogaart C; Kermaniarab V; Ellison GW; Myers LW
J Immunol; 1984 Oct; 133(4):1931-7. PubMed ID: 6088630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
